CD4 is also expressed in Peripheral T-cell lymphomas (PTCLs) and CD4CAR NK-92 cells could also eliminated CD4+ T-cell leukemia and lymphoma cells in vitro and reduced tumor burden and prolonged survival in a T cell lymphoma xenograft model (192). This evidence concerns the gene CD4 and neoplasm.